Shelf Life
Period during which a device remains suitable for its intended use under specified conditions.
Definition
Shelf life is supported by accelerated aging and real-time aging studies, often per ASTM F1980, that demonstrate package integrity and product performance over time. Accelerated aging uses elevated temperature and the Arrhenius-based Q10 approach to simulate time, but real-time aging data must follow to confirm the claimed date. Studies typically cover sterile barrier integrity (ISO 11607 with tests such as seal strength and dye penetration), product functionality and, for some devices, material degradation. The shelf life claim on the label must be supported by these studies in the technical documentation.What this means in practice
Shelf-life claims appear in labeling and must be supported by valid data. Extension studies are common as real-time data accumulates.Examples
- A manufacturer performs accelerated aging on a new sterile catheter package to support a preliminary 3-year shelf life claim, while simultaneously initiating real-time aging studies.
- A company submits data from ongoing 5-year real-time aging studies to the FDA to extend the shelf life of their implantable device from 3 years to 5 years.
- During a design change to a drug-eluting stent, the manufacturer conducts new accelerated and real-time aging studies to ensure the drug elution profile and stent integrity are maintained over the original shelf life.
- •A common pitfall is relying solely on accelerated aging data without initiating or completing real-time aging studies, which are crucial for conclusive shelf life determination.
- •Manufacturers sometimes fail to consider the impact of packaging degradation on device sterility or functionality throughout the claimed shelf life.
- •Another mistake is not establishing a clear, scientifically sound justification for the chosen accelerated aging conditions, potentially leading to invalid shelf life claims.
- •Inadequate sample sizes for aging studies can lead to statistically unreliable data, making it difficult to defend shelf life claims during regulatory audits.
- •Failing to re-evaluate shelf life after design changes or material substitutions can result in non-compliant products on the market.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsManufacturing & Supply Chain
· From this learning pathAbility of a material to perform with an appropriate host response in a specific application.
Formal QMS process for evaluating, approving, and implementing changes that could affect product quality or compliance.
Installation, Operational, and Performance Qualification - the three stages of equipment and process qualification.
Biological evaluation of medical devices within a risk management process.
More in Quality & Risk
· Same categoryFailure of a product, process, or system to meet specified requirements.
Verification step confirming a corrective or preventive action actually fixed the problem.
Process for receiving, evaluating, and responding to device complaints.
Where this term appears across MedTech Terms.
- Manufacturing & Supply ChainLesson 8 of 14
Latest in MedTech
Sources
3 sourcesEvery citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 1ASTM F1980Tier 1 VerifiedASTMastm.org
- 2MDIC Case for QualityTier 4 VerifiedMDICmdic.org
- 3FDA - Quality SystemsTier 2 VerifiedFDAfda.gov
Inline markers like [1] jump to the matching reference above.